Compounds > platinum
Page last updated: 2024-08-22

platinum and Carcinoma, Epidermoid

platinum has been researched along with Carcinoma, Epidermoid in 111 studies

Research

Studies (111)

TimeframeStudies, this research(%)All Research%
pre-199016 (14.41)18.7374
1990's17 (15.32)18.2507
2000's12 (10.81)29.6817
2010's41 (36.94)24.3611
2020's25 (22.52)2.80

Authors

AuthorsStudies
Fukuda, N; Hara, Y; Horita, N; Kaneko, A; Kaneko, T; Kobayashi, N; Namkoong, H; Somekawa, K; Tagami, Y; Watanabe, K1
Dong, X; Jia, Y; Song, X; Song, Y; Wang, W; Yi, Y; Zhang, J1
Cai, L; Chen, C; Deng, H; Li, S; Lin, X; Liu, M; Qin, Y; Qiu, G; Xie, X; Xie, Z; Yang, Y; Zhou, C1
Chang, JH; Chang, TH; Chen, WT; Chien, LN; Chou, YT; Chung, CL; Hong, SY; Hsiao, SH; Lin, SE1
Cui, GH; Deng, YW; Li, SH; Li, YJ; Li, YW; Lu, D1
Han, SB; He, Y; Liu, Y; Wu, YM; Zhang, JJ1
Anandappa, G; Arnold, D; Capdevila, J; Catlett, M; Cornfeld, M; Dahan, L; Demols, A; Evesque, L; Fakih, M; Gilbert, DC; Guren, MG; Jensen, LH; Kayyal, T; Kim, S; Rao, S; Samalin, E; Saunders, MP; Smith, M; Spano, JP; Spindler, KL; Tamberi, S; Tian, C1
Rodriguez, E; Santos, ES1
Akimoto, T; Daiko, H; Fujita, T; Fujiwara, H; Hojo, H; Ito, R; Kojima, T; Nakamura, N; Nakamura, Y; Sunakawa, H; Yano, T; Yoshino, T1
Guo, Y; Liu, Y; Xia, Z; Xue, L; Zhang, Q1
Gibson, MK; Weidenbaum, C1
Fushimi, C; Hanyu, K; Ito, T; Kondo, T; Masubuchi, T; Matsuki, T; Miura, K; Okada, T; Okamoto, I; Omura, GO; Oridate, N; Sato, H; Tada, Y; Takahashi, H; Tokashiki, K; Tsukahara, K; Yamashita, T1
Chen, C; Chen, H; Chen, T; Du, W; Fu, S; He, LN; Hong, S; Lin, Z; Zhang, X; Zhou, Y1
Biancalana, L; Ermini, ML; Frusca, V; Giannini, N; Gonnelli, A; Mapanao, AK; Marchetti, F; Santi, M; Sarogni, P; Voliani, V; Zamborlin, A1
Biswas, S; Ghosh, B; Itoo, AM; Paul, M1
Hao, Y; Jin, J; Si, J; Song, Z; Wei, J; Xiang, J; Xu, C1
Acharya, R; Anderson, JL; Delgoffe, GM; Ferris, RL; Harris, AL; Hsieh, RW; Li, J; Menk, AV; Nilsen, ML; Scheff, NN; Swartz, A; Zandberg, DP1
Argiris, A; Bratland, Å; Chung, CH; Coutte, A; de Azevedo, S; Even, C; Fayette, J; Ferris, RL; Gillison, M; Grant, C; Grell, P; Haddad, R; Hansen, AR; Harrington, KJ; Khan, TA; Miller-Moslin, K; Redman, R; Roberts, M; Salas, S; Schenker, M; Soulières, D; Tahara, M; Walker, JWT; Wei, L1
Chen, WW; Chu, XY; Huang, QC; Lu, L; Sun, Q; Wang, JH; Wang, R; Wang, T1
Edwards, A; Falk, S; Hackshaw, A; Hatton, M; Jones, R; Lal, R; Lee, SM; Lewanski, C; Ngai, Y; Rudd, R; Skailes, G; Toy, E; Upadhyay, S; Woll, PJ1
Hamburger, T; Kadouri, L; Lipson, D; Nechushtan, H; Peretz, T; Rottenberg, Y; Zick, A1
Bradford, DS; Crane, J; Deal, AM; Irvin, W; Lee, C; Morgensztern, D; Muss, HB; Pecot, C; Pennell, N; Socinski, M; Stevenson, JP; Stinchcombe, T; Villaruz, LC; Weiss, JM; West, HJ1
Gupte-Singh, K; Le, TK; Lubinga, SJ; Penrod, JR; Smith, CB; Stenehjem, DD; Zhang, Y1
Kato, S; Miwa, N; Saitoh, Y1
Abakumov, MA; Abdul Razak, IB; Aisa, HA; Akhmirov, RT; Aladinskaya, AV; Allem, JP; Allu, SR; Ambale-Venkatesh, B; Anasori, B; Arizcorreta, A; Armentrout, PB; Baumann, H; Beloglazkina, EK; Ben-Elyiahu, Y; Ber, AP; Berthon, C; Bettelheim, A; Bluemke, DA; Bonsignore, M; Bordet, A; Borruso, A; Boxer, MB; Bress, AP; Brimacombe, KR; Brown, DE; Brüggemann, M; Cafeo, A; Cao, K; Cao, L; Carnicelli, J; Carr, JC; Cavallo, L; Cazin, CSJ; Cheff, DM; Chen, G; Chen, H; Chen, J; Chen, R; Chen-Sankey, JC; Cheng, C; Cheng, Y; Cheruku, RR; Chida, N; Choi, K; Chu, M; Cipolli, M; Colantonio, LD; Collado, A; Cook, J; Cordes, DB; Covey, J; Cuesta-Sancho, S; Davis, MI; Demireva, M; Derington, CG; Di Rosa, G; Dicanio, D; Dong, G; Dontsova, OA; Dormanesh, A; Dovrat, G; Duan, XM; Duarte, DA; Efthymiou, S; Erofeev, AS; Falivene, L; Fang, Y; Feng, D; Fernandes, VRS; Finko, AV; Freitag, TM; Frye, S; Gachot, C; Gao, S; Garanina, AS; Getya, D; Girón-González, JA; Girón-Ortega, JA; Gitsov, I; Gorelkin, PV; Grützmacher, PG; Guo, PY; Gutiérrez-Saborido, D; Habibi, M; Hall, MD; Hayes-Ryan, D; He, ZZ; Henderson, MJ; Herrick, JS; Herrmann, H; Hoang, Y; Hofmann, W; Hollingshead, M; Houlden, H; Hu, L; Huang, B; Huang, Y; Hussain, M; Huynh, HP; Iansa, P; Ivanenkov, YA; Jadhav, A; Jalaludin, B; Jalava, P; Karavadhi, S; Karpasas, M; Katahara, S; Kawel-Boehm, N; Khazanova, ES; King, JB; Klumpp-Thomas, C; Knibbs, LD; Komiya, Y; Komppula, M; Kranidiotis-Hisatomi, N; Krasnovskaya, OO; Kwiezinski, C; Lee, SW; Lee, TD; Leitner, W; Lerner, A; Leskinen, A; Li, B; Li, J; Li, Y; Li, Z; Liang, D; Liao, HB; Lima, JAC; Lin, L; Lin, W; Lin, Z; Liu, H; Liu, K; Liu, L; Liu, Q; Liu, Y; Lu, K; Luo, M; Ma, B; Machulkin, AE; Maimon, E; Majouga, AG; Márquez-Coello, M; Martinez, NJ; McCarthy, C; McIver, A; Meaney, S; Melotti, P; Menin, L; Mertes, S; Michael, S; Missert, JR; Moisy, P; Monda, KL; Mondello, P; Moore, WJ; Mücklich, F; Mues, KE; Muntner, P; Nahra, F; Navar, AM; Nelson, DJ; Nelson, RE; Ni, S; Nicotera, AG; Nimenko, EA; Nolan, SP; O'Donoghue, K; Oestreich, M; Pandey, RK; Pang, RD; Patnaik, S; Pei, W; Petrov, SA; Pevzner, S; Phillips, KS; Pintani, E; Pironti, E; Pokrovsky, VS; Polshakov, VI; Poudel, B; Pragani, R; Presser, V; Qu, H; Rahsepar, AA; Ramsey, MW; Ravotto, L; Ren, D; Ren, G; Ren, L; Rogach, AL; Rohde, JM; Roponen, M; Rosen, BD; Rosenkranz, A; Rosenson, RS; Salpietro, V; Saltykova, IV; Sato, T; Saveliev, OY; Senger, AR; Shafikov, RR; Shataer, D; Shen, M; Shi, Y; Shu, X; Simeonov, A; Skvortsov, DA; Slawin, AMZ; Smirnova, GB; Song, G; Stevens, VW; Stott, GM; Stratmann, F; Su, BJ; Suarez, S; Sugiyama, Y; Tabaczynski, W; Teo, KL; Tolosa, A; Totorika, A; Tracy, EC; Treggiari, D; Tridello, G; Troxler, T; Urban, DJ; Uspenskaya, AA; Vainer, R; Van Hecke, K; van Pinxteren, D; Vanden Broeck, SMP; Vanneman, ME; Vinogradov, SA; Wang, B; Wang, H; Wang, HS; Wang, L; Wang, R; Wang, X; Wang, YQ; Weller, C; Winkler-Heil, R; Xia, F; Xiao, F; Xin, XL; Xing, H; Xu, J; Xu, SL; Xu, Z; Yamane, M; Yamansarov, EU; Yan, T; Yang, BY; Yang, G; Yang, L; Yang, P; Yang, X; Yao, T; Yasgar, A; Ye, N; Yi, H; Yin, C; Yu, DYW; Yu, HY; Yu, J; Yuan, M; Zagefka, H; Zeng, XW; Zhang, H; Zhang, S; Zhang, W; Zhao, D; Zhao, W; Zhao, X; Zheng, H; Zheng, YK; Zhu, X; Zilbermann, I; Zyk, NU; Zyk, NV1
Feng, Y; Jiang, W; Kang, Y; Li, G; Li, J; Ma, H; Yu, X; Zhang, C1
Cang, S; Chen, G; Cui, J; Du, Y; Fan, M; Fan, Y; Fang, J; Hu, C; Huang, D; Li, B; Li, J; Li, Y; Liu, L; Sun, P; Wang, S; Wang, Z; Wu, L; Xue, J; Yang, Z; Zhang, L; Zhang, W; Zhao, H; Zhou, C; Zhou, H; Zhou, J1
Fujimoto, E; Okame, S; Okazawa-Sakai, M; Shiroyama, Y; Takehara, K; Yokoyama, T1
Chen, X; Cheng, R; Chu, HY; Jiang, YE; Qi, X; Sun, CZ; Wang, W; Zeng, MS; Zhong, ZM; Zhu, XF1
Cai, Y; Han, W; Kang, A; Song, C; Wang, Y; Wang, Z; Wei, Z; Xu, W; Yin, X; Zhang, J1
Si, X; Wang, H; Wang, M; Wu, S; Zeng, X; Zhang, L; Zhang, X1
Ariyoshi, W; Enomoto, Y; Iwanaga, K; Matsumura, Y; Matsuo, K; Nishihara, T; Okinaga, T; Sasaguri, M; Tanaka, M; Tominaga, K; Toyono, T1
Tahara, M1
de Castria, TB; Fujiki, FK; Hoff, PMG; Takeda, FR; Victor, CR1
Braakhuis, BJ; Brakenhoff, RH; Brink, A; Dalm, SU; Honeywell, RJ; Martens-de Kemp, SR; Peters, GJ; Wijnolts, FM1
Cai, Y; Chen, H; Gao, Z; Han, B; Jiang, G; Li, X; Lu, D; Qian, J; Su, B; Tan, X; Wang, J; Wang, S; Wu, Q; Yang, Y; Zhao, X1
Chan, C; Colevas, AD; Jiang, W; Kong, C; Le, QT; Lee-Enriquez, N; Murphy, JD; Pinto, H; Tang, C; von Eyben, R1
Alves, MP; Avezedo, I; de Mello, RA; Dinis, J; Gerós, S; Moreira, F1
Cohen, EE; Haddad, RI; Licitra, LF; Machiels, JP; Tahara, M1
Alakus, H; Bollschweiler, E; Drebber, U; Eberz, PM; Frazer, KA; Harismendy, O; Hölscher, AH; Lowy, AM; Maus, M; Metzger, R; Mönig, SP; Siffert, W; Warnecke-Eberz, U1
Georgoulias, V; Giagkas, G; Ioannidis, G; Koutsopoulos, A; Lagoudaki, E; Mavroudis, D; Papadaki, C; Sfakianaki, M; Souglakos, J; Trypaki, M; Tsakalaki, E; Voutsina, A1
Hamaguchi, T; Honma, Y; Iwasa, S; Kato, K; Nagashima, K; Nishikawa, A; Okita, N; Sasaki, Y; Sawada, R; Shimada, Y; Shirakawa, T; Shoji, H; Takahashi, N; Takashima, A; Yamada, Y1
Fukuda, S; Furusawa, J; Hatakeyama, H; Homma, A; Iizuka, S; Kano, S; Mizumachi, T; Onimaru, R; Sakashita, T; Shirato, H; Tsuchiya, K; Yasuda, K1
Maeda, A; Nakata, M; Nojima, Y; Okita, R; Saisho, S; Shimizu, K; Yukawa, T1
Caponigro, F; Clement, PM; Cohen, EE; Cong, XJ; Cupissol, D; de Castro, G; de Souza Viana, L; Del Campo, JM; Ehrnrooth, E; Fayette, J; Gauler, T; Grau, JJ; Guigay, J; Haddad, RI; Keilholz, U; Licitra, LF; Machiels, JP; Tahara, M; Vermorken, JB2
Bail, JP; Brigand, C; Collet, D; Gronnier, C; Lebreton, G; Luc, G; Mabrut, JY; Mariette, C; Meunier, B1
Blumenschein, GR; Canales, JR; Ginsberg, LE; Heymach, JV; Kies, MS; Lee, JJ; Lin, H; Lu, C; Massarelli, E; Papadimitrakopoulou, V; Tran, HT; Williams, MD1
Hassan, U; Mozayani, B; Wong, NA1
Adkins, D; Aguilar, JL; Bryant, K; Chang, SC; Chen, E; Chin, S; Ernst, S; He, S; Lee, HJ; Misiukiewicz, K; Obasaju, CK; Soulières, D1
Guancial, E; Iczkowski, KA; Kilari, D; Kim, ES; Messing, EM; Pandya, C; Robin, AJ1
Binder, M; Bokemeyer, C; Braig, F; Busch, CJ; Grob, T; Knecht, R; Kriegs, M; Laban, S; Schieferdecker, A; Voigtlaender, M1
Cheng, L; Jia, M; Qiu, L; Wang, M; Wei, Q; Xiang, J; Zhou, F; Zhu, M1
Cohen, C; Hanley, KZ; Horowitz, IR; Khanna, N; Rubinsak, LA1
Berghmans, T; Biesma, B; Chittazhathu Kurian Kuruvilla, Y; Ciardiello, F; Coate, L; Cobo Dols, M; Collado Martin, R; Cuffe, S; Curioni-Fontecedro, A; Dafni, U; de Hosson, S; Garde Noguera, J; Gasca-Ruchti, A; Gautschi, O; Gregorc, V; Groen, HJM; Horgan, A; Insa, A; Juan Vidal, Ó; Kassapian, M; Láng, I; López Martín, A; Mark, MT; Massutí, B; Meldgaard, P; Novello, S; Palmero Sanchez, R; Peralta, S; Peters, S; Pieterman, R; Ponce Aix, S; Rauch, D; Smit, EF; Stahel, RA; Summers, Y; Torri, V; Tsourti, Z; van den Berg, PM; van Heemst, R; van Henten, AMJ; Villa Guzmán, JC; Zielinski, CC1
Aimone, P; Alyasova, A; Barone, C; Chakravartty, A; Chol, M; Dechaphunkul, A; Erfán, J; Faivre, S; Hirawat, S; Karpenko, A; Kasper, S; Kim, SB; Kiss, LA; Li, SH; Licitra, L; Lin, JC; Mesía, R; Nagarkar, R; Ochsenreither, S; Remenár, É; Soulières, D; Tamás, L; Turri, S1
Jeremić, B; Milicić, B1
Enomoto, T; Fukutsuji, K; Ikeda, H; Kitano, H; Morizane, R; Nakahara, K; Nosaka, A; Sakoda, T; Shibano, A; Yamanishi, M1
Ciuleanu, T; Darstein, CL; Latz, JE; Musib, LC; Specenier, PM; Vermorken, JB1
Cho, JH; Jang, TW; Kim, CS; Kim, HJ; Kim, HT; Kim, SK; Kim, YH; Kwak, SM; Lee, JE; Ryu, JS; Shin, ES; Yoo, YK; Yun, MH1
Crysandt, M; Esser, A; Jost, E; Osieka, R; von Hobe, S; Wilop, S1
Chun, KC; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Nam, JH1
Benasso, M; Erfán, J; Hitt, R; Kawecki, A; Licitra, L; Mesia, R; Remenár, É; Rivera, F; Rottey, S; Senger, S; Störkel, S; Stroh, C; Vermorken, JB; Zabolotnyy, D1
Eguchi, K; Ichinose, Y; Kishi, K; Minato, K; Nishikawa, M; Nogami, N; Okamoto, H; Seki, N; Seto, T; Shinkai, T; Takiguchi, Y; Watanabe, K1
Berard, H; Bota, S; Chouaid, C; Corre, R; Crequit, J; Dujon, C; Paillotin, D; Robinet, G; Thomas, P; Vergnenegre, A1
Argiris, A; Ballas, MS; Belani, CP; Davies, A; Edelman, M; Gandara, DR; Gitlitz, BJ; Groshen, S; Hoffman, P; Koczywas, M; Liu, SV; Ramalingam, S; Tsao-Wei, DD; Vokes, EE1
Burhenne, J; Detering, JC; Dyckhoff, G; Haefeli, WE; Herold-Mende, C; Theile, D; Weiss, J1
Cohen, J; Halm, EA; Mandeli, J; Mhango, G; Sigel, K; Strauss, G; Wisnivesky, J1
Duan, Z; He, C; Li, P; Xu, Q; Yuan, Y1
Correa, AM; Erasmus, JJ; Gold, KA; Heymach, J; Kalhor, N; Kim, ES; Lee, JJ; Munden, R; Papadimitrakopoulou, V; Pataer, A; Rice, DC; Swisher, SG; William, WN; Wistuba, II1
Arias-Pulido, H; Bauman, JE; Bishop, J; Chung, CH; Fekrazad, MH; Fertig, E; Howard, J; Jones, DV; Lee, SJ; Olson, GT; Ozawa, H; Spafford, MJ; Wang, H1
Ito, K; Nagase, S; Nemoto, K; Niikura, H; Ogawa, Y; Takano, T; Yaegashi, N; Yoshinaga, K1
Boku, N; Ebihara, M; Iida, Y; Onitsuka, T; Onozawa, Y; Zenda, S1
Cannon, M; Cmelak, AJ; Forastiere, AA; Gillison, M; Goldwasser, MA; Li, S; Murphy, B; Pinto, H; Rosenthal, DI1
Ervin, TJ; Fabian, RL; Miller, D; Norris, CM; Posner, MR; Rose, C; Weichselbaum, RR1
Kuhn, JG; Mattox, DE; Repta, AJ; Sternson, LA; Von Hoff, DD1
Gall, HE; Klein, I; Pinedo, HM; van der Vijgh, WJ; Vermorken, JB1
Fujii, M; Horiuchi, M; Inuyama, Y; Kohno, N; Mashino, S1
Henkel, H; Nagel, GA; von Heyden, HW; Weinstock, N1
Asfaw, I; Buroker, T; Dindogru, A; Franklin, R; Hoschner, D; Knechtges, T; Leichman, L; Loh, JJ; Miller, P; Pietruk, T; Rosenberg, JC; Seydel, H; Steiger, Z; Torres, A; Vaishamapayan, G; Vaitkevicius, V; Wilson, RF1
Bernard, JP; Fournel, P; Jorda, M; Laennec, E; Piperno, D; Rebattu, P; Souquet, PJ; Trillet, V1
Asanami, S; Susami, E; Uchiyama, K1
Murakami, T; Nagai, N; Ohama, K1
Hamada, M; Kohso, T; Shimamoto, T; Tateyama, H1
Aggarwal, SK; Gemma, NW; Herold, DA; Kinter, M; Nicholson, J; Shipe, JR1
Cavallin-Stahl, E; Johnsson, A1
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T1
Bakker, PJ; Blommaert, FA; Geerdink, A; Haveman, J; Rietbroek, RC; van de Vaart, PJ; Veenhof, CH1
Baan, RA; Braakhuis, BJ; Cloos, J; Fichtinger-Schepman, AM; Hermsen, MA; van der Vijgh, WJ; Welters, MJ1
Harada, N; Hori, Y; Kawamoto, K; Kumazawa, H; Sai, S; Tachikawa, T; Yamashita, T; Yodosawa, S1
Braakhuis, BJ; Cloos, J; Fichtinger-Schepman, AM; Pankras, JE; Smeets, SJ; Welters, MJ1
Brès, J; Constans, B; Cupissol, D; Gau, F; Gory-Delabaere, G; Nouguier-Soulé, J1
Areberg, J; Johnsson, A; Mattsson, S; Norrgren, K; Wennerberg, J1
Hamana, S; Ku, Y; Maruo, T; Miyahara, Y; Motoyama, S; Takeuchi, S; Tateiwa, Y; Yoshida, S1
Kumada, K; Makuuchi, M; Midorikawa, T; Nemoto, H; Sanada, Y; Sasaya, S; Takeuchi, S; Takizawa, K; Uemichi, O; Yamaguchi, M; Yoshizawa, Y1
Brasnu, D; Hans, S; Laccourreye, H; Laccourreye, O; Ménard, M; Veivers, D1
Carr, DT; Coles, DT; Eagan, RT; Frytak, S; Ingle, JN; Kvols, LK; O'Fallon, JR; Rubin, J1
Holding, JD; Lindup, WE; Schilling, V; Stell, PM; van Laer, C; Vreeburg, GC; Wilson, JA1
Akita, H; Fijita, H; Haneda, H; Katabami, M; Kawakami, Y; Kuzumaki, N; Miyamoto, H1
Francois, E; Frenay, M; Milano, G; Namer, M; Troger, V1
Brann, TW; Frei, E; Herman, TS; Holden, SA; Khandekar, V; Korbut, TT; Rosbe, KW; Sotomayor, EA; Teicher, BA1
Bowdler, DA; Holding, JD; Lindup, WE; Siodlak, MZ; Stell, PM1
Breau, JL; Clavier, J; Gres, JJ; Israël, L; Lerebours-Pigeonnière, G; Morère, JF; Nouvet, G; Raut, Y; Zabbe, C1
Ebihara, T; Fukushima, M; Kawakami, S; Maruyama, K; Sawada, T; Tateyama, Y; Yoshimura, Y1
Herman, TS; Teicher, BA; Wang, Y1
Hayashibara, K; Hirosawa, A; Niitani, H; Tsuboi, E1
Atkinson, N; Castellanos, AM; Choksi, AJ; Dimery, IW; Felder, TB; Hong, WK; McCarthy, K; Newman, RA; Paredes, J; Robbins, KT1
Delobelle, A; Demaille, MC; Fournier, C; Hecquet, B; Lequint, A; Poissonnier, B; Vennin, P1
Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J1
Abrams, MJ; Holden, SA; Jacobs, JL; Jones, AG; Teicher, BA1
Cucchi, CA; Frei, E; Henner, WD; Holden, SA; Kelley, MJ; Rosowsky, A; Shea, TC; Teicher, BA1

Reviews

4 review(s) available for platinum and Carcinoma, Epidermoid

ArticleYear
Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis.
    Thoracic cancer, 2022, Volume: 13, Issue:1

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Lung Neoplasms; Nivolumab; Platinum; Progression-Free Survival; Randomized Controlled Trials as Topic

2022
Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the Lung.
    Clinical lung cancer, 2022, Volume: 23, Issue:6

    Topics: Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Humans; Lung; Lung Neoplasms; Platinum

2022
Approach to Localized Squamous Cell Cancer of the Esophagus.
    Current treatment options in oncology, 2022, Volume: 23, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Epithelial Cells; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Paclitaxel; Platinum; Quality of Life

2022
Intracellular calcium changes and chemosensitivities of human epidermoid carcinoma cell lines after exposure to cisplatin.
    The Annals of otology, rhinology, and laryngology, 1998, Volume: 107, Issue:7

    Topics: Antineoplastic Agents; Calcium; Carcinoma, Squamous Cell; Chemoreceptor Cells; Cisplatin; Humans; KB Cells; Nasopharyngeal Neoplasms; Platinum; Tumor Cells, Cultured

1998

Trials

32 trial(s) available for platinum and Carcinoma, Epidermoid

ArticleYear
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202).
    ESMO open, 2022, Volume: 7, Issue:4

    Topics: Anal Canal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Anus Neoplasms; Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Platinum

2022
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
    European journal of cancer (Oxford, England : 1990), 2019, Volume: 120

    Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biomarkers, Tumor; Blood Proteins; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Double-Blind Method; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Predictive Value of Tests; Protein Kinase Inhibitors; Proteomics; Survival Rate

2019
Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy.
    Cancer, 2020, 03-01, Volume: 126, Issue:5

    Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Albumins; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Paclitaxel; Platinum; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate

2020
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12).
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021, Volume: 16, Issue:9

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Deoxycytidine; Double-Blind Method; Gemcitabine; Humans; Lung Neoplasms; Platinum

2021
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy.
    BMC cancer, 2014, Jun-28, Volume: 14

    Topics: Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Protocols; Disease Progression; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Retreatment; Squamous Cell Carcinoma of Head and Neck

2014
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
    The Lancet. Oncology, 2015, Volume: 16, Issue:5

    Topics: Adult; Afatinib; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome

2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:7

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Everolimus; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Salvage Therapy; Survival Rate

2015
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen.
    BMC cancer, 2016, Jan-14, Volume: 16

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemistry, Pharmaceutical; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum; Squamous Cell Carcinoma of Head and Neck

2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:8

    Topics: Afatinib; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome

2016
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic On
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2017, Volume: 12, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Docetaxel; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Staging; Platinum; Prognosis; Survival Rate; Taxoids

2017
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
    The Lancet. Oncology, 2017, Volume: 18, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Double-Blind Method; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; International Agencies; Male; Middle Aged; Morpholines; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Platinum; Prognosis; Survival Rate

2017
Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy.
    American journal of clinical oncology, 2008, Volume: 31, Issue:3

    Topics: Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Dose Fractionation, Radiation; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Platinum; Prognosis; Radiation Dosage

2008
[Docetaxel (TXT) and irinotecan (CPT-11) as a second-line chemotherapy for platinum-pretreated squamous cell carcinoma of the head and neck].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Docetaxel; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Irinotecan; Male; Middle Aged; Platinum; Taxoids

2008
Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Cisplatin; Cross-Over Studies; Dietary Supplements; Female; Glutamates; Guanine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Platinum; Prognosis; Treatment Outcome

2009
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:5

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cetuximab; ErbB Receptors; Fluorouracil; Gene Dosage; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Survival Analysis; Treatment Outcome; Young Adult

2011
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Deoxycytidine; Drug Combinations; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Platinum; Salvage Therapy; Survival Rate; Tegafur; Time Factors; Treatment Outcome

2011
Cost-effectiveness of second-line chemotherapy for non-small cell lung cancer: an economic, randomized, prospective, multicenter phase III trial comparing docetaxel and pemetrexed: the GFPC 05-06 study.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Platinum; Prospective Studies; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome

2011
A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Ethers, Cyclic; Female; Follow-Up Studies; Furans; Humans; Ketones; Lung Neoplasms; Macrolides; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome

2012
Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.
    Anti-cancer drugs, 2013, Volume: 24, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Confidence Intervals; DNA-Binding Proteins; Endonucleases; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nuclear Proteins; Platinum; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Transcription Factors; Transcription Initiation Site; Treatment Outcome; Young Adult

2013
A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma.
    Oral oncology, 2013, Volume: 49, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Class I Phosphatidylinositol 3-Kinases; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Platinum; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; Quinazolines; Ribosomal Protein S6 Kinases; Sirolimus; Survival Rate; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins

2013
Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
    Gynecologic oncology, 2007, Volume: 104, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Organoplatinum Compounds; Platinum; Radioisotope Teletherapy; Uterine Cervical Neoplasms

2007
Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Sep-01, Volume: 25, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Deglutition Disorders; Female; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Pharyngectomy; Platinum; Radiotherapy, Adjuvant; Recovery of Function; Salvage Therapy; Speech Disorders; Taxoids; Treatment Outcome

2007
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
    Bulletin du cancer, 1993, Volume: 80, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Platinum; Vindesine

1993
Neoadjuvant chemotherapy using a platinum, vincristine and peplomycin (CVP) combination in patients with carcinoma of the uterine cervix.
    Asia-Oceania journal of obstetrics and gynaecology, 1993, Volume: 19, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Peplomycin; Platinum; Survival Rate; Uterine Cervical Neoplasms; Vincristine

1993
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine

1996
Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum.
    American journal of clinical oncology, 2001, Volume: 24, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Feasibility Studies; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Staging; Platinum; Uterine Neoplasms

2001
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
    Cancer treatment reports, 1977, Volume: 61, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Galactitol; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Sugar Alcohols

1977
Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck.
    British journal of clinical pharmacology, 1992, Volume: 33, Issue:1

    Topics: Carcinoma, Squamous Cell; Cisplatin; Drug Compounding; Drug Evaluation; Head and Neck Neoplasms; Humans; Platinum; Serum Albumin

1992
Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:4

    Topics: Adenocarcinoma; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Humans; Kidney; Lung Neoplasms; Platinum; Random Allocation; Thiosulfates; Time Factors; Vindesine

1989
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Ditiocarb; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Prospective Studies; Random Allocation

1988
Comparative study of intravenous and intraarterial cis-platinum on intratumoral platinum concentration in carcinoma of the cervix.
    Gynecologic oncology, 1989, Volume: 32, Issue:2

    Topics: Adult; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Injections, Intra-Arterial; Injections, Intravenous; Middle Aged; Platinum; Uterine Cervical Neoplasms

1989
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer.
    American journal of clinical oncology, 1987, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation

1987

Other Studies

75 other study(ies) available for platinum and Carcinoma, Epidermoid

ArticleYear
Neoadjuvant chemotherapy with liposomal paclitaxel plus platinum for locally advanced esophageal squamous cell cancer: Results from a retrospective study.
    Thoracic cancer, 2022, Volume: 13, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epithelial Cells; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Retrospective Studies

2022
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Gemcitabine; Humans; Lung Neoplasms; Paclitaxel; Platinum; Prospective Studies; Retrospective Studies

2023
Comparative survival analysis of platinum-based adjuvant chemotherapy for early-stage squamous cell carcinoma and adenocarcinoma of the lung.
    Cancer medicine, 2022, Volume: 11, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Platinum; Survival Analysis

2022
Advanced thymic lymphoepithelioma-like carcinoma with bone marrow metastases treated by immunotherapy combined with antiangiogenesis therapy: a case report.
    Anti-cancer drugs, 2022, 08-01, Volume: 33, Issue:7

    Topics: Bone Marrow Neoplasms; Bone Neoplasms; Carcinoma, Squamous Cell; Humans; Immunotherapy; Platinum

2022
Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
    BMC cancer, 2022, Apr-14, Volume: 22, Issue:1

    Topics: Apolipoprotein A-I; Breast Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Phosphatidylinositol 3-Kinases; Platinum; Uterine Cervical Neoplasms

2022
Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma.
    Esophagus : official journal of the Japan Esophageal Society, 2022, Volume: 19, Issue:4

    Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Neoplasm Recurrence, Local; Platinum; Radiotherapy, Conformal; Retrospective Studies

2022
Combined taxane, platinum, and cetuximab as a first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma: Retrospective study.
    Head & neck, 2022, Volume: 44, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids

2022
Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.
    Anticancer research, 2022, Volume: 42, Issue:10

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Nivolumab; Platinum; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck

2022
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Platinum; Programmed Cell Death 1 Receptor; Retrospective Studies

2022
Hybrid nano-architectures loaded with metal complexes for the co-chemotherapy of head and neck carcinomas.
    Journal of materials chemistry. B, 2023, 01-04, Volume: 11, Issue:2

    Topics: Carcinoma, Squamous Cell; Cisplatin; Coordination Complexes; Head and Neck Neoplasms; Humans; Platinum; Squamous Cell Carcinoma of Head and Neck

2023
Hypoxia alleviating platinum(IV)/chlorin e6-based combination chemotherapeutic-photodynamic nanomedicine for oropharyngeal carcinoma.
    Journal of photochemistry and photobiology. B, Biology, 2023, Volume: 238

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Chlorophyllides; Head and Neck Neoplasms; Hypoxia; Mice; Mouth Neoplasms; Nanomedicine; Nanoparticles; Oxygen; Photochemotherapy; Photosensitizing Agents; Platinum; Porphyrins; Squamous Cell Carcinoma of Head and Neck

2023
Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma.
    Current oncology (Toronto, Ont.), 2022, 12-02, Volume: 29, Issue:12

    Topics: Carcinoma, Squamous Cell; Humans; Platinum; Retrospective Studies; Thymoma; Thymus Neoplasms

2022
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck.
    Oral oncology, 2023, Volume: 140

    Topics: Analgesics, Opioid; Antibodies, Monoclonal; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Female; Head and Neck Neoplasms; Humans; Immunotherapy; Male; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment

2023
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial.
    JAMA oncology, 2023, Jun-01, Volume: 9, Issue:6

    Topics: Carcinoma, Squamous Cell; Double-Blind Method; Head and Neck Neoplasms; Humans; Immunotherapy; Ipilimumab; Male; Middle Aged; Neoplasm Recurrence, Local; Nivolumab; Platinum; Squamous Cell Carcinoma of Head and Neck

2023
[Primary squamous cell carcinoma of the prostate: Clinical features and therapeutic strategies].
    Zhonghua nan ke xue = National journal of andrology, 2022, Volume: 28, Issue:12

    Topics: Carcinoma, Squamous Cell; Humans; Male; Platinum; Prognosis; Prostate

2022
Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization.
    Lung cancer (Amsterdam, Netherlands), 2019, Volume: 137

    Topics: Adenocarcinoma of Lung; Aged; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Protein; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fanconi Anemia Complementation Group N Protein; Female; Follow-Up Studies; Germ-Line Mutation; Homologous Recombination; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Platinum; Prognosis; Retrospective Studies; Survival Rate

2019
Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non-Small-Cell Lung Cancer in the United States.
    Clinical lung cancer, 2021, Volume: 22, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Nivolumab; Platinum; Prognosis; Retrospective Studies; Survival Rate; United States

2021
Carcinostatic effects of alkanoyl ascorbate plus platinum nano-colloid and stabilization of the esterolytically resultant ascorbate by hydrogen.
    Human cell, 2021, Volume: 34, Issue:2

    Topics: Antineoplastic Agents; Ascorbic Acid; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colloids; Esophageal Neoplasms; Humans; Hydrogen; Nanocomposites; Platinum; Water

2021
    Journal of applied social psychology, 2021, Volume: 51, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antigens, Surface; Antineoplastic Agents; Antioxidants; Antiviral Agents; Aporphines; Atherosclerosis; Benzoyl Peroxide; beta Catenin; Biofilms; Biomarkers; Brain; Cannabis; Carcinoma, Squamous Cell; Case-Control Studies; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Child; China; Chlorides; Chlorophyll; Cholesterol, LDL; Coinfection; Corylus; Cross-Sectional Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Developmental Disabilities; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Electroencephalography; Environmental Exposure; Enzyme Inhibitors; Epilepsy, Generalized; Ethnicity; Female; Fertilization in Vitro; Fluorescent Dyes; Follow-Up Studies; Forecasting; Glutamate Carboxypeptidase II; Glycine; Half-Life; Head and Neck Neoplasms; Health Communication; Heart Ventricles; Hepacivirus; Hepatitis C; Heterosexuality; HIV Infections; Humans; Hypercholesterolemia; Immunoassay; Inhalation Exposure; Isocitrate Dehydrogenase; Laryngeal Neoplasms; Ligands; Light; Lipopolysaccharide Receptors; Liver Cirrhosis; Lung; Lung Neoplasms; Magnetic Resonance Imaging, Cine; Male; Maternal Age; Mechanical Phenomena; Mice; Mice, Nude; Mice, SCID; Microglia; MicroRNAs; Microscopy, Fluorescence; Microsomes, Liver; Middle Aged; Minority Groups; Mitochondrial Membrane Transport Proteins; Models, Biological; Molecular Structure; Molecular Weight; Monte Carlo Method; Muscle Hypotonia; Mutagenesis, Site-Directed; Mutation, Missense; Natriuretic Peptide, Brain; Neoplasms; Nickel; Nitric Oxide; Optical Imaging; Oxides; Particle Size; Particulate Matter; PCSK9 Inhibitors; Peptide Fragments; Phenotype; Photochemotherapy; Photosensitizing Agents; Phytochemicals; Piper; Placenta Growth Factor; Plant Extracts; Plant Leaves; Plant Stems; Platinum; Point-of-Care Testing; Population Surveillance; Postpartum Period; Pregnancy; Pregnancy, Twin; Prevalence; Prospective Studies; Prostatic Neoplasms; Pseudomonas aeruginosa; Pyridines; Pyridones; Racial Groups; Rats; Respiratory Physiological Phenomena; Retrospective Studies; Risk Factors; RNA, Long Noncoding; Semiconductors; Sexual and Gender Minorities; Sexual Behavior; Social Media; Sodium; Solubility; Stereoisomerism; Stochastic Processes; Structure-Activity Relationship; Substance-Related Disorders; Sustained Virologic Response; Sweat; Temperature; Time Factors; Tissue Distribution; Titanium; Transplantation, Heterologous; Tumor Cells, Cultured; Tungsten; Tyramine; United States; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Function, Left; Veterans; Xenograft Model Antitumor Assays; Young Adult

2021
Neoadjuvant treatment of pembrolizumab plus platinum-doublet chemotherapy in stage IIIA squamous cell carcinoma of the lung: a case report.
    Annals of palliative medicine, 2021, Volume: 10, Issue:3

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Platinum

2021
Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
    International journal of clinical oncology, 2018, Volume: 23, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Platinum; Postoperative Care; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Uterine Cervical Neoplasms; Young Adult

2018
Bafilomycin A1 increases the sensitivity of tongue squamous cell carcinoma cells to cisplatin by inhibiting the lysosomal uptake of platinum ions but not autophagy.
    Cancer letters, 2018, 06-01, Volume: 423

    Topics: Autophagy; Autophagy-Related Protein 5; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Humans; Lysosomes; Macrolides; Platinum; Proto-Oncogene Proteins c-abl; Tongue Neoplasms

2018
Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Hypoxia; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cisplatin; Drug Delivery Systems; Drug Resistance, Neoplasm; Graphite; Humans; Hydrogen-Ion Concentration; Male; Mice, Inbred BALB C; Mouth Neoplasms; Nanocomposites; Platinum; Quantum Dots; Tumor Microenvironment

2018
Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma.
    Thoracic cancer, 2018, Volume: 9, Issue:8

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Therapy; ErbB Receptors; Female; Gene Dosage; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Retrospective Studies; Survival Analysis; Treatment Outcome

2018
Anticancer effect of novel platinum nanocomposite beads on oral squamous cell carcinoma cells.
    Journal of biomedical materials research. Part B, Applied biomaterials, 2019, Volume: 107, Issue:7

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Male; Mice; Mice, Nude; Mouth Neoplasms; Nanocomposites; Platinum; Xenograft Model Antitumor Assays

2019
[The Concept of Platinum-Resistance and Treatment Strategies in Head and Neck Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:5

    Topics: Carcinoma, Squamous Cell; Cetuximab; Drug Resistance, Neoplasm; Head and Neck Neoplasms; Humans; Platinum

2019
Safety and Effectiveness of Chemotherapy for Metastatic Esophageal Cancer in a Community Hospital in Brazil.
    Journal of global oncology, 2019, Volume: 5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carcinoma, Squamous Cell; Esophageal Neoplasms; Hospitals, Community; Humans; Irinotecan; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel; Platinum; Retrospective Studies; Survival Analysis; Treatment Outcome

2019
DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Adducts; DNA, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Head and Neck Neoplasms; Humans; Inhibitory Concentration 50; Mutation; Platinum; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Statistics, Nonparametric; Tumor Suppressor Protein p53

2013
Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
    Clinical lung cancer, 2014, Volume: 15, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Genotype; Haplotypes; Hematologic Diseases; Histocompatibility Antigens Class II; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis

2014
Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer.
    Head & neck, 2015, Volume: 37, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Risk Assessment; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome

2015
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Disease-Free Survival; Europe; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Grading; Platinum; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome

2014
Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.
    Annals of surgical oncology, 2014, Volume: 21, Issue:13

    Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemoradiotherapy; Chromogranins; Esophageal Neoplasms; Female; Follow-Up Studies; Genotype; GTP-Binding Protein alpha Subunits, Gs; Homozygote; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis; Survival Rate

2014
PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.
    British journal of cancer, 2014, Oct-28, Volume: 111, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carrier Proteins; Deoxycytidine; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Membrane Proteins; Middle Aged; Neoplasm Staging; Pemetrexed; Platinum; Prognosis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids; Thyroid Hormone-Binding Proteins; Thyroid Hormones

2014
A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy.
    Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Platinum; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome

2014
Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
    Acta oto-laryngologica, 2015, Volume: 135, Issue:8

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Female; Head and Neck Neoplasms; Humans; Incidence; Japan; Male; Middle Aged; Mucositis; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck

2015
Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
    World journal of surgical oncology, 2015, Feb-06, Volume: 13

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cyclooxygenase 2; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate; Tegafur

2015
Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Annals of surgical oncology, 2015, Volume: 22 Suppl 3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; France; Humans; Incidence; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate

2015
Primary combined neuroendocrine carcinoma (small-cell type) and squamous cell carcinoma of the colon.
    Histopathology, 2016, Volume: 68, Issue:5

    Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Colon; Colonic Neoplasms; Etoposide; Fatal Outcome; Humans; Male; Platinum; Point Mutation; Proto-Oncogene Proteins p21(ras); Tomography, X-Ray Computed

2016
Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients.
    Anticancer research, 2016, Volume: 36, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cation Transport Proteins; Copper Transporter 1; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Prognosis; Urinary Bladder Neoplasms

2016
Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.
    Oncotarget, 2016, Jul-12, Volume: 7, Issue:28

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Drug Resistance, Neoplasm; ErbB Receptors; Fluorouracil; GTP Phosphohydrolases; Head and Neck Neoplasms; High-Throughput Nucleotide Sequencing; Humans; Liquid Biopsy; Membrane Proteins; Mutation; Platinum; Proto-Oncogene Proteins p21(ras); ras Proteins

2016
Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
    Journal of translational medicine, 2016, 05-31, Volume: 14, Issue:1

    Topics: Asian People; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Demography; Disease-Free Survival; DNA Repair; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Genetic Association Studies; Humans; Kaplan-Meier Estimate; Multivariate Analysis; Platinum; Polymorphism, Single Nucleotide; Prognosis; ROC Curve

2016
Folate Receptor Alpha Expression in Platinum Resistant/Refractory Ovarian Carcinomas and Primary Endocervical Adenocarcinomas.
    Applied immunohistochemistry & molecular morphology : AIMM, 2018, Volume: 26, Issue:8

    Topics: Adenocarcinoma; Adolescent; Adult; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Female; Folate Receptor 1; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Ovarian Neoplasms; Platinum; Uterine Cervical Neoplasms

2018
Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Dec-20, Volume: 26, Issue:36

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Gene Frequency; Genotype; Haplotypes; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Polymorphism, Genetic; Prognosis; Ubiquitin-Protein Ligases

2008
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy.
    Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Prognosis; Retrospective Studies; Survival Rate

2009
Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports.
    Japanese journal of clinical oncology, 2010, Volume: 40, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cesarean Section; Female; Humans; Hysterectomy; Magnetic Resonance Imaging; Neoadjuvant Therapy; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Cervical Neoplasms

2010
Cellular pharmacokinetic/pharmacodynamic relationship of platinum cytostatics in head and neck squamous cell carcinoma evaluated by liquid chromatography coupled to tandem mass spectrometry.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:1

    Topics: Aged; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatography, Liquid; Cytostatic Agents; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Platinum; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck; Tandem Mass Spectrometry

2012
Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease.
    Annals of surgical oncology, 2013, Volume: 20, Issue:3

    Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; SEER Program; Survival Rate

2013
Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Tomography, X-Ray Computed

2013
Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Japanese journal of clinical oncology, 2007, Volume: 37, Issue:7

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Tolerance; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Taxoids; Treatment Outcome

2007
The role of chemotherapy for advanced carcinoma of the supraglottic and glottic larynx.
    Otolaryngologic clinics of North America, 1984, Volume: 17, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Glottis; Humans; Laryngeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Platinum

1984
Tumor concentration of platinum in patients with head and neck cancer.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1983, Volume: 91, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Cisplatin; Dogs; Dose-Response Relationship, Drug; Drug Resistance; Head and Neck Neoplasms; Humans; In Vitro Techniques; Platinum

1983
Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications.
    European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:11

    Topics: Aged; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Tongue Neoplasms

1982
[Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:4

    Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cisplatin; Head and Neck Neoplasms; Humans; Kinetics; Platinum; Spectrophotometry, Atomic

1982
[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)].
    Klinische Wochenschrift, 1982, Mar-01, Volume: 60, Issue:5

    Topics: Adult; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Kinetics; Lung Neoplasms; Lymphoma; Male; Middle Aged; Ovarian Neoplasms; Platinum; Testicular Neoplasms

1982
Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy, and surgical therapy.
    The Journal of thoracic and cardiovascular surgery, 1981, Volume: 82, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagus; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycins; Platinum

1981
[A study of intra-arterial infusion with carboplatin (CBDCA) for 2 patients with maxillary gingival cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7

    Topics: Aged; Carboplatin; Carcinoma, Squamous Cell; Female; Gingival Neoplasms; Humans; Infusions, Intra-Arterial; Male; Maxilla; Platinum

1994
[Distribution of platinum in the female genital tract after intraarterial carboplatin infusion during the operation of uterine cervical cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:12

    Topics: Adenocarcinoma; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Genitalia, Female; Humans; Infusions, Intra-Arterial; Intraoperative Care; Lymph Nodes; Platinum; Uterine Cervical Neoplasms

1994
Determination of platinum in urine, ultrafiltrate, and whole plasma by isotope dilution gas chromatography-mass spectrometry compared to electrothermal atomic absorption spectrometry.
    Analytical biochemistry, 1993, Volume: 210, Issue:1

    Topics: Carcinoma, Squamous Cell; Cisplatin; Evaluation Studies as Topic; Gas Chromatography-Mass Spectrometry; Humans; Laryngeal Neoplasms; Male; Middle Aged; Platinum; Spectrophotometry, Atomic

1993
A topographic study on the distribution of cisplatin in xenografted tumors on nude mice.
    Anti-cancer drugs, 1996, Volume: 7, Issue:1

    Topics: Animals; Carcinoma, Squamous Cell; Cisplatin; DNA Adducts; Mice; Mice, Inbred BALB C; Mice, Nude; Platinum; Transplantation, Heterologous; Tumor Cells, Cultured

1996
Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells.
    Journal of cancer research and clinical oncology, 1997, Volume: 123, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Cyclobutanes; DNA Adducts; DNA, Neoplasm; Humans; Hyperthermia, Induced; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Platinum; Tumor Cells, Cultured

1997
Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines.
    International journal of cancer, 1997, May-02, Volume: 71, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Differentiation; Cell Division; Cell Line; Cisplatin; DNA, Neoplasm; Female; Head and Neck Neoplasms; Humans; Kinetics; Male; Middle Aged; Platinum; Time Factors; Tumor Cells, Cultured

1997
Effect of cisplatin exposure on platinum accumulation and growth inhibition in human neoplastic and normal squamous epithelial cells of the mucosa of the upper-aerodigestive tract.
    Cancer letters, 1999, Apr-26, Volume: 138, Issue:1-2

    Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Epithelial Cells; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Platinum; Tumor Cells, Cultured; Uvula

1999
[Pharmacologic markers predictive of neutropenia chemically induced by cisplatin (CDDP)].
    Journal de la Societe de biologie, 1999, Volume: 193, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Choriocarcinoma; Cisplatin; DNA Adducts; Drug Monitoring; Female; Fluorouracil; Humans; Lymphocytes; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms; Platinum; Predictive Value of Tests; Saliva

1999
Antitumor effect of radioactive cisplatin (191Pt) on nude mice.
    International journal of radiation oncology, biology, physics, 2001, Mar-01, Volume: 49, Issue:3

    Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Platinum; Radiation-Sensitizing Agents; Radioisotopes; Transplantation, Heterologous

2001
[Tissue platinum distribution and the effect following intra-arterial injection of cisplatin to metastatic liver cancer--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Fluorouracil; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Platinum; Tissue Distribution

2001
Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders.
    Cancer, 2001, Sep-15, Volume: 92, Issue:6

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasms, Second Primary; Pharyngeal Neoplasms; Platinum; Salvage Therapy

2001
Reduced drug accumulation in a newly established human lung squamous-carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Biochemical pharmacology, 1992, Jul-22, Volume: 44, Issue:2

    Topics: Carcinoma, Squamous Cell; Cell Division; Cell Line; Cisplatin; Drug Resistance; Humans; Lung Neoplasms; Platinum; Tetrazolium Salts; Thiazoles

1992
Analysis of tissue platinum distribution in patients with cancer of the oesophagus.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:3

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophagus; Humans; Male; Middle Aged; Platinum

1991
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
    International journal of cancer, 1991, Jan-21, Volume: 47, Issue:2

    Topics: Adenocarcinoma; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; DNA; Drug Resistance; Glutathione Transferase; Humans; Lung Neoplasms; Melanoma; Neoplasms; Organoplatinum Compounds; Platinum; Sulfhydryl Compounds; Tumor Cells, Cultured

1991
Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
    British journal of clinical pharmacology, 1991, Volume: 32, Issue:2

    Topics: Adult; Aged; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Platinum; Serum Albumin

1991
Preliminary results of preoperative chemotherapy with a combination of platinum-bleomycin administered in 5-day cycles in carcinoma of the bronchus.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1986, Volume: 103

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Platinum; Postoperative Complications; Vindesine

1986
[Balloon occluded arterial infusion (BOAI) therapy in patients with progressive cervical carcinoma].
    Nihon Sanka Fujinka Gakkai zasshi, 1989, Volume: 41, Issue:3

    Topics: Aclarubicin; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Catheterization; Cisplatin; Embolization, Therapeutic; Evaluation Studies as Topic; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Platinum; Remission Induction; Tissue Distribution; Uterine Cervical Neoplasms

1989
Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatment.
    British journal of cancer, 1989, Volume: 59, Issue:5

    Topics: Bleomycin; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Cisplatin; Coloring Agents; DNA Repair; DNA, Neoplasm; Humans; Platinum; Tongue Neoplasms

1989
Intracellular distribution of a platinum-rhodamine 123 complex in cis-platinum sensitive and resistant human squamous carcinoma cell lines.
    Biochemical pharmacology, 1986, Oct-01, Volume: 35, Issue:19

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line; Cisplatin; Drug Resistance; Fluorescence; Humans; Organoplatinum Compounds; Platinum; Radiation-Sensitizing Agents; Rhodamine 123; Rhodamines; Xanthenes

1986
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Cancer research, 1987, Jan-15, Volume: 47, Issue:2

    Topics: Biological Transport; Cadmium; Carboplatin; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Cisplatin; Drug Resistance; Glutathione Transferase; Humans; Metallothionein; Organoplatinum Compounds; Platinum; Structure-Activity Relationship; Sulfhydryl Compounds

1987